Taiyen Biotech Co (TPE:1737) Other Current Payables: NT$335 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1737 Taiyen Biotech Co Ltd TPE:1737
82 GF Score
Price NT$31.95
GF Value NT$32.06
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Taiyen Biotech Co Other Current Payables?

Taiyen Biotech Co TPE:1737 +0.31% 82 Other Current Payables is NT$335 Mil as of Dec. 2025. GuruFocus rates TPE:1737 with a GF Score™ of 82/100 and a GF Value™ of NT$32.06 (Fairly Valued). The stock has 1 warning sign investors should review.

Taiyen Biotech Co's Other Current Payables for the quarter that ended in Dec. 2025 was NT$335 Mil.

Taiyen Biotech Co's quarterly Other Current Payables declined from Jun. 2025 (NT$533 Mil) to Sep. 2025 (NT$328 Mil) but then increased from Sep. 2025 (NT$328 Mil) to Dec. 2025 (NT$335 Mil).

Taiyen Biotech Co's annual Other Current Payables increased from Dec. 2023 (NT$311 Mil) to Dec. 2024 (NT$348 Mil) but then declined from Dec. 2024 (NT$348 Mil) to Dec. 2025 (NT$335 Mil).

Taiyen Biotech Co Other Current Payables Related Terms

Taiyen Biotech Co Other Current Payables Historical Data

* Premium members only.

The historical data trend for Taiyen Biotech Co's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Taiyen Biotech Co Other Current Payables Chart

Taiyen Biotech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 310.44 288.75 311.40 347.56 335.01

Taiyen Biotech Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 347.56 212.83 532.59 327.56 335.01
TPE:1737
82GF Score
Taiyen Biotech Co Ltd TPE:1737
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Taiyen Biotech Co Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of NT$335 Mil mean?
Taiyen Biotech Co (TPE:1737) has a Other Current Payables of NT$335 Mil as of Dec. 2025. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Taiyen Biotech Co and its competitors.
Is Taiyen Biotech Co's Other Current Payables too high?
Taiyen Biotech Co's current Other Current Payables is NT$335 Mil. Overall, Taiyen Biotech Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Taiyen Biotech Co's Other Current Payables compare to PG and CL?
Taiyen Biotech Co's Other Current Payables of NT$335 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Consumer Packaged Goods company?
A good Other Current Payables depends on the Consumer Packaged Goods industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Taiyen Biotech Co and its competitors. Taiyen Biotech Co's current Other Current Payables is NT$335 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiyen Biotech Co stock overvalued right now?
Based on GuruFocus' analysis, Taiyen Biotech Co (TPE:1737) is currently considered Fairly Valued. The stock's GF Value™ is NT$32.06, compared to a current price of NT$31.95 — trading 0.3% below its estimated fair value. The current Other Current Payables is NT$335 Mil. Taiyen Biotech Co's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Taiyen Biotech Co (TPE:1737), the current Other Current Payables is NT$335 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Taiyen Biotech Co (TPE:1737) Overvalued in 2026?

Based on GuruFocus' analysis, Taiyen Biotech Co stock appears to be undervalued. The current stock price of NT$31.95 is trading 0.3% below its estimated GF Value™ of NT$32.06. GuruFocus considers Taiyen Biotech Co to be Fairly Valued.

Key valuation signals for TPE:1737:

  • Other Current Payables: NT$335 Mil
  • GF Value™: NT$32.06 vs. price of NT$31.95 (0.3% below fair value)
  • GF Score™: 82/100 with 1 warning sign

No single metric tells the full story. See the TPE:1737 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Taiyen Biotech Co Business Description

Address No. 297, Section 1, Chien-Kang Road, South District, Tainan, TWN
Taiyen Biotech Co Ltd operates in personal care and home care products. Its product portfolio comprises beauty care products, health food, skin products, salt products and spices, bottled water, and medical supplies, among others. The group has four reportable segments; Salt products and packaged water department, Biotech cleaning and maintenance department, Construction and services department, and Other departments.. The Salt and Packaged Product Segment accounts for the bulk of revenue. Geographically it operates through the region of Taiwan; however, it also holds a presence in the international market.
82GF Score

Get the complete analysis for TPE:1737

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.95
Price
NT$32.06
GF Value